<DOC>
	<DOCNO>NCT02856295</DOCNO>
	<brief_summary>The aim study compare anti-10a level postpartum woman receive different prophylactic dos LMWH : one group LMWH dose adjust woman 's weight second group receive 1mg/kg maximum dose 120 mg</brief_summary>
	<brief_title>anti10a Levels Women Treated With LMWH Postpartum Period</brief_title>
	<detailed_description>pregnancy postpartum period associate increase risk thromboembolism . risk increase woman thrombophilia . This risk high postpartum period compare pregnancy period , especially risk pulmonary embolism ( PE ) . The American College Of Obstetrics Gynecologists , The American college chest physicians The Royal College obstetricians gynecologist recommend use low molecular weight heparin postpartum period woman thrombophilia woman risk factor develop thromboembolism . specific guideline regard best protocol base level anti-10 . This study compare two protocol base anti-10a level .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>postpartum woman suppose receive LMWH accord obstetric indication know allergy clexane active bleeding postpartum thrombocytopenia &lt; 75000 recent cerebrovascular accident / transient ischemic attack ( &lt; 4 week ) glomerular filtration rate ) &lt; 30 ml/min ) active liver disease malignant hypertension ( systolic &gt; 200 mmHg , diastolic &gt; 120 mmHg )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>postpartum venous thromboembolism</keyword>
	<keyword>prophylactic dose low molecular weight heparin</keyword>
	<keyword>anti 10a</keyword>
</DOC>